About
Patient Care
Education
Research
Community
Feb 22, 2024 | UCI News
UC Irvine study shows similarities and differences in human and insect vision formation
Discovery offers insights into retinal disease origins and potential therapeutic targets.
Jan 09, 2024 | UCI News
School of Medicine Receives Prestigious Grant from Research to Prevent Blindness
The University of California, Irvine School of Medicine has received a prestigious Unrestricted Grant from the nonprofit organization Research to Prevent Blindness. The five-year, $575,000 grant will support eye research conducted by the Department of Ophthalmology.
Oct 19, 2020 | National Eye Institute
UCI-led study reveals significant restoration of retinal and visual function following gene therapy
UCI researchers working on a breakthrough study have results showing the restoration of retinal and visual functions of mice models suffering from inherited retinal disease.
Matt Miller Director, Communications and Public Relations mrmille2@uci.edu
Michelle Strombeck Manager, Communications and Public Relations 312-498-8208 mstrombe@hs.uci.edu
Stay Connected
A research team led by the UC Irvine School of Medicine has identified a potential new gene-independent therapeutic strategy for treating the millions of people worldwide who suffer from retinal degeneration, a group of diseases that can lead to vision loss.
Chief of Pediatric Ophthalmology at UCI Health Gavin Herbert Eye Institute, Donny Suh, MD whom leads it's Eye Mobile for Children develops special eye wear for kids. Made with a 3D printer, these inexpensive spectacles provide vision correction for children with head or facial abnormalities who are unable to wear regular frames, as well as kids whose families who can't afford glasses.
UCI professor and Director of the Laboratory of Cellular and Molecular immunology at the Gavin Herbert Eye Institute, Lbachir BenMohamed, PhD, alongside colleagues across the UCI School of Medicine have demonstrated in pre-clinical studies that combining their broad-based antigen approach with current COVID-19 vaccines gives better protection against illness from repeated infection by many virus variants. BenMohamed points out that SARS-CoV-2 is unlikely to be the last coronavirus to cause widespread disease. He hopes that his lab’s vaccine approach will make it possible to respond quickly with effective therapies when the need arises.
Mar 18, 2024 | ASCRS EyeWorld
Treatment of limbal stem cell deficiency
Identifying and treating patients with limbal stem cell dysfunction or deficiency can be a challenging process. Several physicians discussed how they handle these patients, including which techniques are available for mild to more severe disease.
Oct 10, 2023 | Review of Ophthalmology
What to do with a White Cataract
The challenges to expect and tips for successful management of these complicated cases.